Pavmed Series Z Stock Buy Hold or Sell Recommendation
| PAVMZ Stock | USD 0.03 0.00 0.00% |
Assuming the 90 days horizon and your conservative attitude towards risk, our recommendation regarding PAVmed Series Z is 'Not Rated'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell PAVmed Series Z given historical horizon and risk tolerance towards PAVmed Series. When Macroaxis issues a 'buy' or 'sell' recommendation for PAVmed Series Z, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. In addition, we conduct extensive research on individual companies such as PAVmed and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards PAVmed Series Z. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
PAVmed |
Execute PAVmed Series Buy or Sell Advice
The PAVmed recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on PAVmed Series Z. Macroaxis does not own or have any residual interests in PAVmed Series Z or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute PAVmed Series' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
PAVmed Series Trading Alerts and Improvement Suggestions
| PAVmed Series Z is not yet fully synchronised with the market data | |
| PAVmed Series Z is way too risky over 90 days horizon | |
| PAVmed Series Z has some characteristics of a very speculative penny stock | |
| PAVmed Series Z appears to be risky and price may revert if volatility continues | |
| PAVmed Series Z has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 2.45 M. Net Loss for the year was (64.17 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| PAVmed Series generates negative cash flow from operations | |
| PAVmed Series Z has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: PAVmed to Hold a Business Update Conference Call and Webcast on November 14, 2024 - StockTitan |
PAVmed Series current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. PAVmed analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. PAVmed analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
PAVmed Series Returns Distribution Density
The distribution of PAVmed Series' historical returns is an attempt to chart the uncertainty of PAVmed Series' future price movements. The chart of the probability distribution of PAVmed Series daily returns describes the distribution of returns around its average expected value. We use PAVmed Series Z price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of PAVmed Series returns is essential to provide solid investment advice for PAVmed Series.
| Mean Return | 10.66 | Value At Risk | -55.87 | Potential Upside | 99.33 | Standard Deviation | 51.38 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of PAVmed Series historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
PAVmed Series Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (2.0M) | 11.0M | 60.0M | (37.5M) | (20.1M) | (19.1M) | |
| Free Cash Flow | (13.4M) | (22.0M) | (42.1M) | (72.5M) | (52.3M) | (49.7M) | |
| Other Non Cash Items | 558.6K | 5.3M | (1.5M) | 11.0M | (3.5M) | (3.3M) | |
| Capital Expenditures | 27.2K | 55K | 1.5M | 1.5M | 242K | 372.6K | |
| Net Income | (17.3M) | (35.9M) | (56.1M) | (103.2M) | (64.2M) | (61.0M) | |
| End Period Cash Flow | 6.2M | 17.3M | 77.3M | 39.7M | 19.6M | 19.0M | |
| Depreciation | 14.2K | 23K | 226K | 2.5M | 2.9M | 3.1M | |
| Investments | (27.2K) | (55K) | (3.7M) | (4.7M) | 643K | 675.2K | |
| Dividends Paid | 67.4B | 357K | 436M | 35.2M | 12.5B | 10.7B |
PAVmed Series Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as PAVmed . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 0.0275 | |||
| Day Typical Price | 0.0275 | |||
| Relative Strength Index | 41.12 |
About PAVmed Series Buy or Sell Advice
When is the right time to buy or sell PAVmed Series Z? Buying financial instruments such as PAVmed Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having PAVmed Series in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Office Supplies Thematic Idea Now
Office Supplies
Companies producing and selling office supplies, and accessories. The Office Supplies theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Office Supplies Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for PAVmed Stock Analysis
When running PAVmed Series' price analysis, check to measure PAVmed Series' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PAVmed Series is operating at the current time. Most of PAVmed Series' value examination focuses on studying past and present price action to predict the probability of PAVmed Series' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PAVmed Series' price. Additionally, you may evaluate how the addition of PAVmed Series to your portfolios can decrease your overall portfolio volatility.